Management & Regulatory

Kenya Invests KES 29 Billion in 13 New Referral Hospitals
Management & Regulatory Kenya Invests KES 29 Billion in 13 New Referral Hospitals

To relieve the overcrowding at national referral centers, the Kenyan government is decentralizing specialized healthcare by building regional facilities in twelve underserved counties. This ambitious initiative involves a KES 29 billion investment to establish thirteen new referral hospitals,

Hims & Hers Enters the Unproven Longevity Peptide Market
Management & Regulatory Hims & Hers Enters the Unproven Longevity Peptide Market

The telehealth industry is currently navigating a complex regulatory landscape as the FDA prepares to finalize rules regarding which specific peptides, such as BPC-157, can be legally compounded. This pivot occurs as Hims & Hers Health, Inc. aggressively shifts its focus toward the burgeoning

Karnataka Launches SAMASTA To Streamline Public Health Data
Management & Regulatory Karnataka Launches SAMASTA To Streamline Public Health Data

Alongside its digital transformation, the Karnataka government is allocating over ten crore rupees to expand mental health services across thirty-one underserved taluks in the Kalyana Karnataka region. This strategic investment forms a core component of the broader SAMASTA initiative, which aims to

Institutional Capital Shifts to Precision Medicine
Management & Regulatory Institutional Capital Shifts to Precision Medicine

The global healthcare landscape is undergoing a monumental transition as the traditional "one-size-fits-all" model gives way to a more sophisticated, precision-based framework. This evolution represents both a significant scientific leap and a massive economic shift that is reshaping how global

Can HEARTS Modernize Mexico’s Cardiovascular Health System?
Management & Regulatory Can HEARTS Modernize Mexico’s Cardiovascular Health System?

Chronic cardiovascular conditions have persisted as the primary cause of mortality across the Mexican landscape, compelling health authorities to overhaul traditional treatment methodologies. Through a strategic alliance with the Pan American Health Organization, the nation has accelerated the

How Will the Again-Geno Deal Revolutionize Biomanufacturing?
Management & Regulatory How Will the Again-Geno Deal Revolutionize Biomanufacturing?

The industrial landscape is currently undergoing a seismic shift as the acquisition of Genomatica by the Danish innovator Again creates a formidable powerhouse capable of redefining the boundaries of sustainable chemical production. This merger represents more than just a corporate expansion; it is

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later